DiscoverX (P)
Which technology is the foundation of many Eurofins DiscoverX cell-based assays?
A. PCR
B. CRISPR
C. Enzyme Fragment Complementation (EFC) Technology
D. Flow Cytometry
What is the primary advantage of Eurofins Discovery's Custom Solutions?
A. Manufacturing approved pharmaceuticals
B. Customizing or developing assays and scientific solutions tailored to a customer's specific drug discovery program
C. Conducting only clinical trials
D. Selling laboratory equipment
Which chemistry disciplines are integrated within Eurofins Discovery's Chemistry platform?
A. Synthetic Chemistry
B. Medicinal Chemistry
C. Computational and Analytical Chemistry
D. All of the above
What is the primary goal of Eurofins Discovery's Biotherapeutics solutions
A. Manufacture commercial biologics
B. Support every stage of biotherapeutics discovery, from target validation to preclinical development
C. Conduct Phase III clinical trials
D. Provide regulatory consulting only
What is the most important first step when engaging with a new biotech customer?
A. Immediately provide a price quotation
B. Understand the customer’s scientific goals, challenges, timeline, and decision criteria
C. Send a list of all available services
D. Discuss only Eurofins Discovery capabilities
What is a major advantage of Assay Ready Kits?
A. Require continuous cell culture
B. Include frozen ready-to-use cells and optimized reagents
C. Used only for animal studies
D. Require proprietary instruments
For small molecule drug discovery, Eurofins Discovery can develop custom assays for which screening stages?
A. High-Throughput Screening (HTS)
B. Hit-to-Lead (H2L)
C. Lead Optimization (LO)
D. All of the above
Why is computational chemistry an important part of Eurofins Discovery's Chemistry services?
A. It replaces laboratory experiments entirely.
B. It helps prioritize compound design and improve decision-making before synthesis.
C. It is used only after clinical trials.
D. It is used exclusively for manufacturing.
What is the primary objective of Antibody Optimization
A. Increase manufacturing costs
B. Improve stability, reduce immunogenicity, and humanize lead antibodies
C. Perform clinical trials
D. Produce vaccines
A customer says, “We already work with another CRO.” What is the best Business Development response?
A. Explain why other CROs are not suitable
B. Offer the lowest possible price immediately
C. Understand their current workflow, identify gaps, and position where Eurofins Discovery can add value
D. End the conversation because they already have a supplier
Which assay kit format is intended primarily for early drug discovery
A. Bioassay Kits
B. eXpress™ Assay Kits
C. Stability Assays
D. GMP Assays
Which of the following assay formats can Eurofins Discovery customize for small molecule discovery?
A. Biochemical assays
B. Enzymatic assays
C. Radioligand and Mass Spectrometry (MS)-based binding assays
D. All of the above
Which customer would benefit most from Eurofins Discovery's integrated Chemistry services?
A. A biotech company optimizing lead compounds
B. A pharmaceutical company advancing preclinical candidates
C. A virtual biotech with limited in-house chemistry resources
D. All of the above
Eurofins Discovery supports end-to-end development of which advanced therapeutic platform?
A. PCR Diagnostics
B. Antibody-Drug Conjugates (ADCs)
C. Medical Imaging
D. Diagnostic Test Kits
Which approach best supports long-term strategic account growth?
A. Focus only on individual project quotations
B. Engage customers proactively to understand future pipelines and identify collaboration opportunities
C. Contact customers only when they request pricing
D. Promote the same service package to every customer
Bioassay Kits are particularly suitable for:
A. Routine laboratory teaching
B. Potency testing, MOA confirmation, and QC lot release
C. DNA sequencing
D. Protein purification
What is the primary focus of Eurofins Discovery's Protein Science team?
A. Manufacturing recombinant proteins for research and drug discovery
B. Producing commercial vaccines
C. Conducting Phase III clinical trials
D. Hospital diagnostics
Eurofins Discovery's Chemistry laboratories are strategically located in which regions?
A. United States only
B. Europe only
C. Spain, the United States, and India
D. China, Japan, and Singapore
What is the purpose of Eurofins Discovery's Gene and Cell Therapy workflow?
A. Manufacture approved commercial therapies
B. Streamline programs from R&D through IND approval
C. Conduct post-market surveillance
D. Provide hospital treatment
During a business review with a strategic customer, which information is most valuable to present?
A. Only the number of quotations submitted
B. Only the total revenue generated
C. Business impact, project outcomes, customer satisfaction, scientific achievements, and future opportunities
D. A complete list of all company services
What is the purpose of the Early Access Program
A. Provide discounted instruments
B. Give customers early access to innovative assays, cell lines, and recombinant proteins
C. Train laboratory personnel
D. Provide regulatory consulting
How does Eurofins Discovery support AI-driven drug discovery?
A. By replacing laboratory experiments with AI
B. By combining AI predictions with wet-lab validation to accelerate hit-to-lead programs
C. By generating regulatory submissions automatically
D. By manufacturing AI-designed molecules
What is a key advantage of integrating Chemistry with Biology during drug discovery?
A. Eliminates biological testing
B. Enables rapid design–make–test cycles using biological data to guide compound optimization
C. Reduces the need for medicinal chemists
D. Guarantees regulatory approval
Which assays are specifically mentioned for Immunogenicity assessment?
A. PCR and ELISA only
B. T-cell, cytokine, and flow cytometry assays
C. Western blot only
D. DNA sequencing only
A biotech customer has a challenging target with no existing assay available. What is the best sales approach?
A. Recommend only standard catalog assays
B. Tell the customer the target is not suitable for drug discovery
C. Explore the scientific challenge and position Custom Solutions or integrated discovery capabilities
D. Focus only on reducing project cost